Journal: PLOS Pathogens
Article Title: Permissive lung neutrophils facilitate tuberculosis immunopathogenesis in male phagocyte NADPH oxidase-deficient mice
doi: 10.1371/journal.ppat.1012500
Figure Lengend Snippet: (A) Experimental design for in vivo neutralization of G-CSF in Mtb infected mice. Six-week old male WT and Nox2 -/- mice (n = 6 per group) were aerosol infected with Mtb K strain. Starting from one week post-infection, 30 μg of anti-G-CSF mAb was intraperitoneally administered to each mouse three times a week (indicated by blue bars). At four weeks post-infection, all mice were autopsied, and immunological analysis, bacterial counting, and histopathological analysis were conducted (indicated by red arrow). Initial CFU = 225. (B) Mycobacterial CFUs in the lungs and spleens of each group at four weeks post-infection were analyzed by calculating the number of colonies and presented in bar graphs. (C) H&E staining was performed on the superior lobes of the right lung at four weeks post-infection to visualize the gross lung pathology. The inflamed area of the H&E-stained samples was quantified in terms of percentage and square millimeters and presented in bar graphs. (D) IFN-γ, IL-1α, IL-1β, IL-17A, IL-6, TNF-α, G-CSF, and BAFF levels in Mtb-infected mouse lung lysates were measured by ELISA and LEGENDplex. (E) IL-10, IL-4, IL-5, and TGF-β levels in Mtb-infected mouse lung lysates were measured by ELISA and LEGENDplex. The cytokine levels are presented in bar graphs. Pulmonary (F) CD11b + Ly6G + neutrophil, (G) CD11b + Ly6G + CXCR2 lo CD62L lo immature neutrophil, and CD11b + Ly6G + CXCR2 hi CD62L hi mature neutrophil populations of Mtb-infected mice at four weeks post-infection. The percentages of each immune cell among lung CD45 + cells or total neutrophils, and total cell counts are presented in bar graphs, along with flow cytometry plots. The experiment was conducted three times. The data are presented as the mean ± SD of six mice in each group. The significance of differences was determined, using the One-way ANOVA test. n . s ., not significant. * p < 0.05. ** p < 0.01.
Article Snippet: Brilliant violet (BV) 605-conjugated mAb against Thy1.2 and CD19; Allophycocyanin (APC)-conjugated mAb against CD45R (B220); BV 421-conjugated mAb against CD45; APC-R700-conjugated mAb against Siglec-F; Fluorescein isothiocyanate (FITC)-conjugated mAb against CD95 (FAS); BV 786-conjugated mAb against CXCR2; and V450- conjugated mAb against Ly6G were purchased from BD Bioscience (San Jose, CA, USA).
Techniques: In Vivo, Neutralization, Infection, Aerosol, Staining, Enzyme-linked Immunosorbent Assay, Flow Cytometry